1
|
Bexte T, Botezatu L, Miskey C, Reindl LM, Campe J, Mertlitz S, Gebel V, Schubert R, Cremer A, Rettinger E, Prommersberger S, Penack O, Wels WS, Hudecek M, Ivics Z, Ullrich E. High antileukemic efficiency of CD19-CAR NK cells engineered with
Sleeping Beauty transposon vectors. KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- T Bexte
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- University Cancer Center (UCT) Frankfurt-Marburg
| | - L Botezatu
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - C Miskey
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - LM Reindl
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
| | - J Campe
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
| | - S Mertlitz
- Charité Universitätsmedizin Berlin, Berlin,
Germany
| | - V Gebel
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- University Cancer Center (UCT) Frankfurt-Marburg
| | - R Schubert
- Department for Children and Adolescents, University Hospital,
Goethe-University, Frankfurt, Germany
| | - A Cremer
- Department of Hematology and Oncology, Johann Wolfgang Goethe
University, Frankfurt, Germany
| | - E Rettinger
- Division of Stem Cell Transplantation and Immunology, Department of
Children and Adolescent Medicine, Hospital of the Goethe University Frankfurt,
60590, Germany
| | - S Prommersberger
- Department of Internal Medicine II, University Hospital
Würzburg, Würzburg, Germany
| | - O Penack
- Charité Universitätsmedizin Berlin, Berlin,
Germany
| | - WS Wels
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- Georg-Speyer-Haus, Institute for Tumor Biology and Experimental
Therapy, Frankfurt am Main, Germany
- German Cancer Consortium (DKTK) partner site Frankfurt/Mainz,
Frankfurt am Main, Germany
| | - M Hudecek
- Department of Internal Medicine II, University Hospital
Würzburg, Würzburg, Germany
| | - Z Ivics
- Division of Medical Biotechnology, Paul Ehrlich Institute, Langen,
Germany
| | - E Ullrich
- Experimental Immunology, Department for Children and Adolescents
Medicine, Hospital of the Goethe University Frankfurt, 60590,
Germany
- Frankfurt Cancer Institute, Goethe University, Frankfurt am Main,
Germany
- University Cancer Center (UCT) Frankfurt-Marburg
- German Cancer Consortium (DKTK) partner site Frankfurt/Mainz,
Frankfurt am Main, Germany
| |
Collapse
|